Clinical impact of the CUPGuide and Comprehensive Cancer Panel in the SUPER national prospective study: experience of the first 2 years (#115)
Tharani Sivakumaran
1
,
Dariush Etemadmoghadam
2
,
Alexandra Murray
3
,
Richard Tothill
4
,
Lisa Guccione
3
,
Ali Freimund
1
,
Ellen Shaeif
3
,
Anna deFazio
5
,
Nicholas Wilcken
6
,
Bo Gao
7
,
Chris Karapetis
8
,
Madhu Singh
9
,
Ian Collins
10
,
Gary Richardson
11
,
Christopher Steer
12
,
Mark Warren
13
,
Cindy Byrant
14
,
Penny Schofield
3
,
David Bowtell
2
,
Linda Mileshkin
1
15
- Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Cancer Genetics & Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Rare Disease Oncogenomics, University of Melbourne, Melbourne, VIC, Australia
- The Westmead Institute for Medical Research, Sydney, NSW, Australia
- Department of Medical Oncology, Westmead Cancer Care Centre, Sydney, NSW, Australia
- Department of Medical Oncology, Crown Princess Mary Cancer Centre, Sydney, NSW, Australia
- Department of Medical Oncology, Flinders University and Flinders Medical Centre, Melbourne, VIC, Australia
- Department of Medical Oncology, Barwon Health Cancer Services, Melbourne, VIC, Australia
- Department of Medical Oncology, South West Regional Cancer Care and Deakin University, Melbourne, VIC, Australia
- Department of Medical Oncology, Cabrini, Melbourne, VIC, Australia
- Department of Medical Oncology, Border Medical Oncology, Melbourne, VIC, Australia
- Department of Medical Oncology, Bendigo Health, Melbourne, VIC, Australia
- SUPER Study Consumer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia